<DOC>
	<DOCNO>NCT01016678</DOCNO>
	<brief_summary>The study involve approximately 105 adolescent ( age 12-17 ) subject screen 4 site across US . All subject enrol treat 4 MILD migraine 6 month period . They require three office visit six month . All subject randomize either Treximet ( 85mg Imitrex/500mg Naproxen Sodium ) Placebo ( sugar-pill ) four five treatment arm 3 1 ratio . A fifth treatment arm treat 4 migraine active drug , Treximet . The hypothesis Treximet prove safe effective treatment population , treatment migraine . And Treximet superior placebo pain free endpoint 2 24 hour .</brief_summary>
	<brief_title>Treximet Early Intervention Adolescent Migraine</brief_title>
	<detailed_description>There two primary treatment comparison study : 1 ) percentage subject ' pain free 2 hour treatment TREXIMET versus placebo across attack , 2 ) percentage subject sustain pain free 24 hour treatment TREXIMET versus placebo across attack . The following alternative hypothesis test see difference proportion subject pain free 2 hour TREXIMET versus placebo attack , OR difference proportion subject sustain pain free 24 hour TREXIMET versus placebo attack .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>1 . Male female subject age 1217 . 2 . Subject migraine without aura ( ICHDII criterion , 1.2.1 1.1 ) . A history least 1 8 attack per month average past 6 month prior screen visit . Attacks moderate severe last least 3 hour . 3 . Subject able distinguish migraine headache determine mild headache become moderate/severe migraine . 4 . Female subject eligible participation provide nonchild bear potential started menses ; stable regimen approve contraception . 5 . Subject subject 's parent legal guardian able read write English . 6 . Subject able read , comprehend , complete subject diary . 7 . Subjects ' parent legal guardian willing able provide Informed Consent prior subject entry study . 8 . Subject willing able provide Informed Assent prior entry study . Exclusion Criteria Subjects meeting follow criterion must enrol study : 1 . Subject &lt; 74 pound ( 33.3kg ) great 260lbs ( 117.9kg ) 2 . Subject great equal 15 headache day per month total . 3 . Subject secondary headache i.e . complex migraine , hemiplegic , basilar . 4 . Subject , investigator opinion likely unrecognized cardiovascular cerebrovascular disease . 5 . Subject uncontrolled hypertension screen take angiotensinconverting enzyme ( ACE ) inhibitor angiotensin receptor blocker . 6 . Subject history congenital heart disease , cardiac arrhythmia require medication , history clinically significant electrocardiogram abnormality , investigator 's opinion , contraindicate participation study . 7 . Subject evidence history ischemic vascular disease include : ischemic heart disease , ischemic abdominal syndrome , peripheral vascular disease , signs/symptoms consistent . 8 . Subject evidence history central nervous system pathology include stroke and/or transient ischemic attack ( TIAs ) , epilepsy structural brain lesion lower convulsive threshold , treat antiepileptic drug seizure control within 5 year prior screen . 9 . Subject history impair hepatic renal function , investigator 's opinion , contraindicate participation study . 10 . Subject hypersensitivity , allergy , intolerance , contraindication use triptan , NSAID , aspirin ( include sumatriptan naproxen preparation ) nasal polyps asthma . 11 . Subject use ergot medication previous three month migraine prophylaxis take medication stabilize least two month either chronic intermittent migraine prophylaxis comorbid condition . 12 . Subject take plan take monoamine oxidase inhibitor ( MAOI ) include herbal preparation contain St. Johns Wort ( Hypericum perforatum ) , anytime within two week prior screen two week past exit study . 13 . Subject history bleed disorder currently take anticoagulant antiplatelet agent . 14 . Subject evidence history gastrointestinal surgery , GI ulceration , perforation past six month , gastrointestinal bleeding past year , evidence history inflammatory bowel disease . 15 . Subject pregnant , actively try become pregnant , breast feeding Subject willing pregnancy test ( ) . 16 . Subject evidence illicit drug alcohol abuse within last year concurrent psychiatric condition , investigator 's opinion , likely interfere study conduct participation trial . 17 . Subject participate investigational drug trial within previous 4 week plan participate another study time study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>